UBB Global Pharm Invest

Advantages

High liquidity - units can be purchased or redeemed any time.
Non-taxable profit - the realized return is not taxable.
Investments/savings diversification - you can allocate your savings into different product types, thus using the advantages of each one of them.
Institutional protection - control by the Financial Supervision Commission, while the fund’s assets are being kept with a depository-bank.
Access to specialized markets - access to markets, which are usually closed or too specialized for individual investors.

Important information

The information provided does not constitute investment consultation, advice, investment research or investment recommendation and should not be construed as such. The value of units of collective investment schemes varies over time and may be higher or lower than the value at the time of investment. No profits are guaranteed and there is a risk risk that investors might not recover the full amount of their investment. It is advisable for investors to get acquainted with the specifics of the financial instruments in which they wish to invest, and to evaluate how appropriate the latter are to meet their investment goals and risk aversion before making an investment decision. Investments in collective investment schemes are not guaranteed by a government-created guarantee fund or any other type of guarantee. Full information regarding investment opprotunities and advice on the most suitable for you mutual funds, can be obtained in UBB branches.

Parameters

UBB Global Farm Invest is focused on shares of leading companies operating in the healthcare sector, mainly in the pharmaceutical, biotechnology and medical equipment segments. It is suitable for investors, who can bear relatively higher risk looking for higher yield of their investments and accepting the possibility of unfavourable changes in the prices of the fund's units.

Fund type	High-risk
Risk indicator	5, based on a scale from 1 (low risk) up to 7 (high risk)
Investment focus:	Shares of leading companies, operating in the healthcare sector, mainly in the pharmaceutical industry, biotechnologies and medical equipment segment
Recommended investment horizon	At least 5 years
Initial offerring start date	30.5.2010
Minimum one-off investment	BGN 100
Minimum investment upon Systematic Investment Plan (SIP)	BGN 100
Currency	Bulgarian leva (BGN)
Depository Bank	EUROBANK BULGARIA EOOD
Issuance fee	2%
Redemption fee	No
Management fee	3.00%
Investor types	Suitable for investors, who, while seeking higher return, are inclined to take the risk of more frequent volatility in unit price
Unit price	See HERE